Mohammad Hossein Somi - Search Results

Year	Number of Results
2004	1
2006	2
2007	2
2008	1
2009	2
2010	3
2011	2
2012	4
2013	6
2014	12
2015	14
2016	11
2017	17
2018	14
2019	19
2020	24
2021	16
2022	18
2023	11
2024	11
2025	5
2026	0

1

Mesalazine vs. IBS-D: Examining its impact on patient symptoms & stool calprotectin levels: A randomized double-blind, placebo-controlled trial.

Somi MH, Faghieh Dinavari M, Sajedi B, Rasooli Manesh SM, Mahdizadeh F, Heydari F. Somi MH, et al. Caspian J Intern Med. 2025 Oct 15;16(4):667-673. doi: 10.22088/cjim.16.4.667. eCollection 2025 Fall. Caspian J Intern Med. 2025. PMID: 41383787 Free PMC article.

2

Core competencies and qualifications of health sciences school managers: a multi-method qualitative study.

Doshmangir L, Jorjani M, Khoshdel A, Kabiri N, Haghparast A, Semnanian S, Sadeghifar J, Mahboubi M, Haghdoost A, Somi MH, Aslanabadi S, Rezapour R. Doshmangir L, et al. BMC Med Educ. 2025 Nov 27;26(1):56. doi: 10.1186/s12909-025-08295-0. BMC Med Educ. 2025. PMID: 41310677 Free PMC article.

3

Association between dietary antioxidant quality score and non-alcoholic fatty liver: a propensity score-matched case-control study in Azar cohort population.

Somi MH, Faramarzi E, Gilani N, Ghalichi F. Somi MH, et al. Br J Nutr. 2025 Nov 21:1-9. doi: 10.1017/S0007114525105655. Online ahead of print. Br J Nutr. 2025. PMID: 41267514

4

Genetic architecture of gastric adenocarcinoma in West Asia.

Latifi-Navid S, Abdi E, Wang T, Pourfarzi F, Yazdanbod A, Salami SA, Safaralizadeh R, Amjadi O, Latifi-Navid H, Safarnejad B, Shokrabadi M, Maleki I, Hosseini V, Valizadeh SM, Pourghasemian M, Abediasl N, Kazemi A, Eslami Jouybari M, Bari Z, Taghvaei T, Yan C, Eftekhar Sadat AT, Moaddab SY, Janbabaei G, Somi MH, Sadjadi A, Shakeri R, Siavoshi F, Fakheri H, Poustchi H, Malekzadeh R, Jin G. Latifi-Navid S, et al. Clin Transl Med. 2025 Oct;15(10):e70489. doi: 10.1002/ctm2.70489. Clin Transl Med. 2025. PMID: 40999796 Free PMC article. No abstract available.

5

Erratum to: "Rectal cancer survival and prognostic factors in Iranian population: A retrospective cohort study" [Cancer Treatment and Research Communications Volume 39, 2024, 100810].

Mirinezhad SK, Akbarzadeh-Khiavi M, Seyednejad F, Somi MH. Mirinezhad SK, et al. Cancer Treat Res Commun. 2025;44:100916. doi: 10.1016/j.ctarc.2025.100916. Epub 2025 Apr 8. Cancer Treat Res Commun. 2025. PMID: 40199657 Free article. No abstract available.

6

The mediation effect of liver and anthropometric indices on the relationship between incidence of diabetes and physical activity: results of 5-year follow up azar cohort study.

Haghshenas R, Gilani N, Somi MH, Faramarzi E. Haghshenas R, et al. BMC Public Health. 2024 Nov 18;24(1):3190. doi: 10.1186/s12889-024-20587-6. BMC Public Health. 2024. PMID: 39558270 Free PMC article.

7

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants.

NCD Risk Factor Collaboration (NCD-RisC). NCD Risk Factor Collaboration (NCD-RisC). Lancet. 2024 Nov 23;404(10467):2077-2093. doi: 10.1016/S0140-6736(24)02317-1. Epub 2024 Nov 13. Lancet. 2024. PMID: 39549716 Free PMC article.

8

Risk estimation of cardiovascular diseases using the World Health Organization/International Society of Hypertension risk prediction charts in the Azar cohort population: Cross-sectional study.

Faramarzi E, Somi MH, Ostadrahimi A, Molani-Gol R, Khamnian Z, Ghaffari S, Amiri B. Faramarzi E, et al. J Cardiovasc Thorac Res. 2024;16(2):88-96. doi: 10.34172/jcvtr.32906. Epub 2024 Jun 25. J Cardiovasc Thorac Res. 2024. PMID: 39253346 Free PMC article.

9

General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants.

NCD Risk Factor Collaboration (NCD-RisC). NCD Risk Factor Collaboration (NCD-RisC). Lancet. 2024 Aug 31;404(10455):851-863. doi: 10.1016/S0140-6736(24)01405-3. Lancet. 2024. PMID: 39216975 Free PMC article.

10

Prevalence and risk factors of gastroesophageal reflux disease in Iran: A cross-sectional analysis from the PERSIAN cohort.

Sadeghi A, Boustani P, Mehrpour A, Asgari AA, Sharafkhah M, Yazdanbod A, Somi MH, Nejatizadeh A, Moradpour F, Rezaeian M, Mansour-Ghanaei F, Shahriari A, Fattahi MR, Hamzeh B, Hosseini SV, Kahnooji M, Gohari A, Khosravifarsani M, Azadeh H, Pashaei MR, Sheibani EM, Fallahzadeh H, Bakhshipour A, Poustchi H, Malekzadeh R. Sadeghi A, et al. PLoS One. 2024 Jul 11;19(7):e0306223. doi: 10.1371/journal.pone.0306223. eCollection 2024. PLoS One. 2024. PMID: 38990911 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Results by year